| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Investigative Ophthalmology & Visual Science, Vol 38, 1998-2007, Copyright © 1997 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
NL Occleston, JT Daniels, RW Tarnuzzer, KK Sethi, RA Alexander, SS Bhattacharya, GS Schultz and PT Khaw
International Collaborative Wound Research Group, Institute of Ophthalmology and Moorfields Eye Hospital, London, United Kingdom.
PURPOSE: To determine the long-term effects of single, 5-minute exposures to 5-fluorouracil (5FU) and mitomycin-C (MMC) on Tenon's capsule fibroblast migration, growth factor production, growth factor receptor expression, and extracellular matrix (ECM) production. METHODS: Monolayer cultures and the overlying growth medium of Tenon's capsule fibroblasts exposed to 5FU (0.25 to 25 mg/ml) or MMC (0.001 to 0.1 mg/ml) were harvested up to 48 days after treatment. The expression of growth factors and growth factor receptors, including transforming growth factor beta (TGFbeta), basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF), and ECM molecules (collagen type I, collagen type III, and fibronectin) were quantitated at the mRNA and protein levels. The ability of fibroblasts exposed to 5FU and MMC to migrate to fetal calf serum was also investigated up to 48 days after treatment. RESULTS: Control cultures were found to produce the growth factors TGFbeta and bFGF but not EGF. Exposure to 5FU or MMC resulted in an initial significant increase (P < 0.05) in the production of TGFbeta and bFGF, with levels then decreasing toward those of controls. Cells exposed to 5FU or MMC exhibited an initial significant decrease (P < 0.05) in the number of TGFbeta, bFGF, and EGF growth factor receptors, with subsequent recovery toward control levels by day 48 after treatment. Both 5FU and MMC caused a significant reduction (P < 0.05) in collagen type I and fibronectin production compared to controls throughout the 48-day culture period. The production of collagen type III was initially elevated (P < 0.05) compared to controls after exposure to 5FU or MMC, production then decreasing toward control levels over the remainder of the 48-day culture period. The migration of cells exposed to 5FU or MMC was significantly reduced (P < 0.05) compared to controls up to 48 days after treatment; these cells exhibited a partial recovery of migratory ability throughout this period. CONCLUSIONS: Fibroblasts whose growth was arrested using single, short exposures to 5FU or MMC appear to be capable of performing several crucial aspects of wound healing, including the expression of growth factors and receptors and ECM molecules and the ability to migrate. These findings may help explain why in some patients treated with antiproliferatives, glaucoma filtration surgery fails because of scarring.
This article has been cited by other articles:
|
|
 |
|
  M. Honjo, H. Tanihara, T. Kameda, T. Kawaji, N. Yoshimura, and M. Araie Potential Role of Rho-Associated Protein Kinase Inhibitor Y-27632 in Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5549 - 5557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priglinger, C. S. Alge, D. Kook, M. Thiel, R. Schumann, K. Eibl, A. Yu, A. S. Neubauer, A. Kampik, and U. Welge-Lussen Potential role of tissue transglutaminase in glaucoma filtering surgery. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3835 - 3845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Crowston, X. Y. Wang, P. T. Khaw, H. Zoellner, and P. R. Healey Human Serum Reduces Mitomycin-C Cytotoxicity in Human Tenon's Fibroblasts. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 946 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Seong, C. Park, C. Y. Kim, Y. J. Hong, H.-S. So, S.-D. Kim, and R. Park Mitomycin-C Induces the Apoptosis of Human Tenon's Capsule Fibroblast by Activation of c-Jun N-Terminal Kinase 1 and Caspase-3 Protease Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3545 - 3552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Eibl, B. Banas, D. Kook, A. V. Ohlmann, S. Priglinger, A. Kampik, and U. C. Welge-Luessen Alkylphosphocholines: A New Therapeutic Option in Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2619 - 2624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. W. BULSTRODE, M. BISSON, B. JEMEC, A. L. PRATT, D. A. MCGROUTHER, and A. O. GROBBELAAR A Prospective Randomised Clinical Trial of the Intra-Operative Use of 5-Fluorouracil on the Outcome of Dupuytren's Disease J Hand Surg Eur Vol., February 1, 2004; 29(1): 18 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P H Constable, J G Crowston, N L Occleston, and P T Khaw The effects of single doses of {beta} radiation on the wound healing behaviour of human Tenon's capsule fibroblasts Br. J. Ophthalmol., February 1, 2004; 88(2): 169 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Daniels, A. D. Cambrey, N. L. Occleston, Q. Garrett, R. W. Tarnuzzer, G. S. Schultz, and P. T. Khaw Matrix Metalloproteinase Inhibition Modulates Fibroblast-Mediated Matrix Contraction and Collagen Production In Vitro Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1104 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rahbar, D. T. Jones, R. C. Nuss, D. W. Roberson, M. A. Kenna, T. J. McGill, and G. B. Healy The Role of Mitomycin in the Prevention and Treatment of Scar Formation in the Pediatric Aerodigestive Tract: Friend or Foe? Arch Otolaryngol Head Neck Surg, April 1, 2002; 128(4): 401 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chang, J. G. Crowston, C. A. Sabin, P. T. Khaw, and A. N. Akbar Human Tenon's Fibroblast-Produced IFN{beta} and the Prevention of T-Cell Apoptosis Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1531 - 1538. [Abstract] [Full Text]
|
|
|
|
|
|
S. CEROVAC, A. AFOKE, A. AKALI, and D. A. McGROUTHER Early Breaking Strength of Repaired Flexor Tendon Treated with 5-Fluorouracil J Hand Surg Eur Vol., June 1, 2001; 26(3): 220 - 223. [Abstract] [PDF]
|
|
|
|
|
|
M. F. Cordeiro, S. S. Bhattacharya, G. S. Schultz, and P. T. Khaw TGF-{beta}1, -{beta}2, and -{beta}3 In Vitro: Biphasic Effects on Tenon’s Fibroblast Contraction, Proliferation, and Migration Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 756 - 763. [Abstract] [Full Text]
|
|
|
|
|
|
M. F. Cordeiro, J. A. Gay, and P. T. Khaw Human Anti-Transforming Growth Factor-{beta}2 Antibody: A New Glaucoma Anti-Scarring Agent Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2225 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Heilmann, P. Schönfeld, T. Schlüter, R. Bohnensack, and W. Behrens-Baumann Effect of the cytostatic agent idarubicin on fibroblasts of the human Tenon's capsule compared with mitomycin C Br. J. Ophthalmol., August 1, 1999; 83(8): 961 - 966. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
